Ceva and INRAE: Research and innovation in animal health
Framework agreement aimed at consolidating collaboration in animal health, the prevention of infectious diseases of animal origin, and the improvement of animal welfare.
Page 3 of articles about vaccine in Press releases
Pharmgate: Aivlosin® WSG approved in U.S. and Canada to control Mycoplasma hyopneumoniae
This approval gives Aivlosin® WSG the broadest label indication of any product for the control of swine respiratory disease (SRD).
The Pirbright Institute: Combining aerosol and injection of a flu vaccine improves protection in pigs
Combining two different routes of administering flu vaccine provides pigs with better protection against disease than using only one method.
Boehringer Ingelheim: Reduction of Salmonella after vaccination with Enterisol® Ileitis
The Paul Ehrlich Institute (PEI) accepted new language on the label of Enterisol® Ileitis, the only global oral live Lawsonia intracellularis vaccine to control Ileitis in swine.
Pharmgate: PRRSGard® vaccine receives 24-month dating
Modified-live PRRS vaccine with innovative chimeric construction from Pharmgate.
Boehringer Ingelheim and Henke-Sass, Wolf develop innovative needle free injection device for pigs
This novel device will bring benefits to swine producers ensuring improved safety and efficacy of vaccination.
Pirbright, ECO Animal Health, The Vaccine Group to develop new PRRS vaccines
"This collaboration... leverages the deep scientific expertise of Pirbright and The Vaccine Group’s novel herpesvirus vector technology in an exciting new approach to PRRSV vaccination.”
Pharmgate: PRRSGard® vaccine now available in U.S. market
Modified-live PRRS vaccine has innovative chimeric construction.
Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Hipradermic® 3.0: It’s time to feel the comfort
Hipra has just launched its Hipradermic® 3.0 device, a new and improved version of Hipradermic®: an intradermal needle-free jet injector for the vaccination of pigs.
The Roslin Institute: Stem cell approach to aid vaccine development
Method of producing blood cells will provide platform to aid development of vaccines against deadly infections in pigs such as ASF and PRRS.
Boehringer Ingelheim’s classical swine fever live vaccine approved
Ingelvac® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.
Pirbright ASF vaccine protects pigs from developing severe disease
100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.
Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX®
Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine. With DiaTEC diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.
Salmonella vaccine now available to UK and Irish pig producers
Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.